Adaptation for Regulatory Application: A Content Analysis of FDA Risk Evaluation and Mitigation Strategies Assessment Plans (2014-2018) Using RE-AIM. [electronic resource]
- Frontiers in public health 2020
- 43 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
2296-2565
10.3389/fpubh.2020.00043 doi
Drug-Related Side Effects and Adverse Reactions Humans Pharmaceutical Preparations Risk Assessment Risk Evaluation and Mitigation United States United States Food and Drug Administration